Crispr Therapeutics
Price & Volume
Stats
See more52W Range | $30.04-$67.88 |
Market Cap | $3.3B |
Shares Short | 20M |
Financials
See moreRevenue (12 Mos) | $37.3M |
Revenue Growth (YoY) | -82.3% |
Gross Profit (12 Mos) | -$393.5M |
Diluted EPS | -$4.34 |
News
See moreYahoo Finance • 15 days ago
3 Magnificent Stocks That Could Double or More by 2030
Yahoo Finance • 20 days ago
4 Beaten-Down Stocks That Could Skyrocket by 50% to 543%, According to Wall Street
Yahoo Finance • 20 days ago
Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought
Yahoo Finance • 24 days ago
Why Biotech Stocks Such as Biohaven, Recursion Pharmaceuticals, and CRISPR Therapeutics Plunged in March
About
CEO | Dr. Samarth Kulkarni Ph.D. |
Address | Baarerstrasse 14, Zug, Switzerland, 6300 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 393 |
